Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
AMD Reshapes Automotive Industry with Advanced AI Engines and Elevated In-Vehicle Experiences at CES 2024
-
XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
-
SYLA Technologies Appoints Takuya Hanada as Chief Financial Officer
-
Edible Garden Launches PulpFlavors.com E-Commerce Site
-
Safe and Green Development Corporation Announces Update on LOI for Acquisition of Xene Real Estate AI Software
-
Leading Energy Experts Set to Tackle Future of Mining at MINEXCHANGE 2024
-
Riot Announces December 2023 Production and Operations Updates
-
Retail Opportunity Investments Corp. Schedules Fourth Quarter and Year-End Earnings Release and Conference Call
-
Samba TV extends Samba AI® to Holistically Measure ROI from Paid Media, Product Placement, and Sports Sponsorship
-
Veeco Announces Upcoming Investor Event
-
African Agriculture Announces Multi-Year Supply Agreement with South Korea-Based Holding Company Dr. Kahn
-
GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients
-
LegalZoom Launches Beneficial Ownership Information Report to Help Businesses Satisfy New Federal Mandate under the Corporate Transparency Act
-
Stran & Company Appoints Ian Thomas Wall as Chief Information Officer
-
Mimecast Announces Acquisition of Elevate Security, Strengthens Commitment to Managing Human Risk
-
Zevra Therapeutics Appoints Global Medical Leader, Adrian Quartel, M.D., FFPM, as Chief Medical Officer
-
Silo Pharma Successfully Completes First Phase of Dose-Ranging Study of SPC-15 an Intranasal Treatment for PTSD
-
Federal Home Loan Bank of Atlanta Announces New Affordable Housing Advisory Council Member
-
LeapCharger Unveils Future of EV Charging: Home Solutions to Hit Supermarket Shelves in Dubai
-
Ebix Annuity Exchange Closes 2023 with Record Annual Volumes of $118 Billion
-
BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer
-
RespireRx Pharmaceuticals Inc. Announces the Publication of a Case Report in which KRM-II-81 Totally Suppressed Epileptiform Activity in Brain Tissue Surgically Removed from Epileptic Patient
-
Mandatory Notification of Trade by Primary Insider
-
LED Lighting and EV Charging Solutions Provider Orion to Participate in Virtual Sidoti Microcap Conf. Weds & Thurs, Jan 17-18; Presentation Jan 18th at 10am ET
-
Healthy Extracts Launches First Anti-Aging Formulation, LONGEVITY
-
Foremost Lithium Announces Receipt of Third $300,000 Grant from The Manitoba Mineral Development Fund (MMDF)
-
Avenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol
-
Rigetti Announces Public Availability of Ankaa-2 System with a 2.5x Performance Improvement Compared to Previous QPUs
-
YieldMax™ ETFs Announces Monthly Distributions on MRNY (128.16%), CONY (126.19%), AIYY (84.20%), SQY (83.05%), AMDY (79.08%) and Others
-
Comera Life Sciences Announces Bridge Financing and Exercise of Take Private Option
-
Kineta to Participate in the 13th Annual LifeSci Partners Corporate Access Event
-
Rocky Mountain Chocolate Schedules Fiscal Third Quarter 2024 Conference Call for January 11, 2024 at 8:30 A.M. ET
-
Ashvattha Therapeutics Announces the Appointment of Mehdi Paborji as Senior Vice President of Technical Operations
-
Golden Grail Beverages Ends 2023 with Milestone Accomplishments: Laying a Foundation for Shareholder Value in 2024
-
Tuttle Capital Management Launches 2x Inverse Regional Bank ETF
-
C-Bond Systems Reviews 2023 Highlights Including Record Revenue
-
Global Mofy Metaverse Limited Sets Up Subsidiary in California, USA to Expand Global Presence and Venture into Hollywood’s Digital Entertainment Market
-
Ostin Technology Group Announces Participation at CES 2024, the Premier Global Technology Trade Show
-
Roper Technologies schedules fourth quarter 2023 financial results conference call
-
Signing Day Sports CEO Provides Letter to Stockholders
-
DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market
-
TransCode Therapeutics Publishes Open Letter Outlining Company’s Progress and Objectives
-
Mobix Labs Awarded M-1 Abrams Tank Contract for U.S. Army
-
Alliance Trust PLC - Net Asset Value
-
Clean Earth Introduces ReSolve™ PFAS Services
-
Hofseth Biocare ASA: EXTRAORDINARY GENERAL MEETING CONCLUDED
-
The Middlefield Banking Company Enhances Leadership Team to Support Continued Growth
-
Jnana Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
Portage Biotech Reports Business and Strategic Update
-
Ultragenyx Receives Positive Recommendation from NICE in the U.K. for Evkeeza® ▼ (evinacumab) for Adolescents and Adults Aged 12 Years and Older with Homozygous Familial Hypercholesterolemia (HoFH)
